Medical Marijuana Advocacy Group Petitions Full DC Circuit to Review Rescheduling Appeal - Americans for Safe Access
Washington, D.C. -- Medical marijuana patient advocacy group Americans for Safe Access (ASA) filed a petition with the federal court of appeals today in a widely watched case that seeks to reclassify marijuana for medical use. Plaintiffs in the case ASA v. Drug Enforcement Administration are requesting a rehearing before the original panel, as well as seeking full (en banc) review by the United States Court of Appeals for the D.C. Circuit. On January 22nd, the D.C. Circuit granted plaintiffs standing -- the right to sue the federal government to reclassify marijuana -- but, in a 2-1 ruling, denied the appeal on the merits by setting a new, virtually-impossible to meet standard for assessing medical efficacy.
Comprehensive Maryland Medical Marijuana Bill to be Heard by House Committees Today - Americans for Safe Access
Annapolis, MD -- A comprehensive statewide medical marijuana bill introduced in January by Maryland House Delegate and Deputy Majority Whip Cheryl Glenn (D-Baltimore) is scheduled to be heard jointly by the House Judiciary Committee and Health and Government Operations Committees at 2pm today. The hearing will feature Dr. David Bearman, a clinician with over 40 years of providing drug abuse treatment and prevention and a recognized national expert on medical marijuana, as well as Irv Rosenfeld, an author and patient who, as part of the federal government's Investigational New Drug Program, receives monthly shipments of medical marijuana from a government-licensed farm at the University of Mississippi.
Hundreds of Medical Marijuana Advocates to Gather in Washington, D.C. for National Conference, to Change Federal Policy - Americans for Safe AccessWashington, D.C. -- The country's leading medical marijuana advocacy group, Americans for Safe Access (ASA), will host a 4-day National Medical Cannabis Unity Conference, "Bridging the Gap Between Public & Policy," this week in Washington, D.C. from February 22-25, 2013. The conference will feature medical and legal experts, elected officials, as well as seasoned advocates from the U.S. and overseas, including Canada, Israel and the Netherlands.
Federal Medical Marijuana Bills Introduced Today in Anticipation of Patient-Led Congressional Lobbying Effort - Americans for Safe Access
Washington, D.C. -- More than a dozen Members of Congress co-introduced legislation today that would reclassify marijuana for medical use and provide federal defendants the right to use state law compliance as evidence in medical marijuana trials, a right they're currently denied. Rep. Earl Blumenauer (D-OR) authored H.R. 689, the "States’ Medical Marijuana Patient Protection Act," which in addition to rescheduling marijuana will allow states to establish production and distribution laws without interference by the federal government, and will remove current obstacles to research. Rep. Sam Farr (D-CA) authored H.R. 710, the "Truth in Trials Act," a separate bill which seeks to overturn the prohibition on medical marijuana evidence in federal court. Both bills were introduced in anticipation of a national medical marijuana conference to be held next week in Washington, D.C. during which hundreds of advocates are expected to meet with their Congressional representatives about the legislation.
Medical Marijuana Group Featured at RAND Conference and Webcast on Public Health Regulations for Marijuana - Americans for Safe Access
Washington, DC -- Medical marijuana advocacy group Americans for Safe Access (ASA) will be featured today in a RAND Drug Policy Research Center conference and webcast discussion on developing public health regulations for marijuana, given the recent passage of "adult use" laws in Colorado and Washington States.
Medical Marijuana Patient Advocacy Group and Herbal Medicine Industry Collaborate to Enhance Product Safety - Americans for Safe Access
Washington, DC -- The Cannabis Committee of the American Herbal Products Association (AHPA), the only national trade association that is focused primarily on herbs and botanicals and herbal products, issued recommendations this week to regulators of dispensaries in California, Colorado, and Massachusetts, and will make similar recommendations in other medical marijuana states over the next few days.